title: Open, single-blind, double-blind: which peer review process do you prefer?
abstract: BMC Pharmacology and Toxicology was created from the merger of two journals within the BMC series published by BioMed Central: BMC Pharmacology and BMC Clinical Pharmacology. BMC Pharmacology operated anonymous peer review whereas BMC Clinical Pharmacology operated a fully open peer review policy where the identity of the reviewers was known to the editors, authors and readers. The merged journal also adopted a fully open peer review policy. Two years on we discuss the views and experiences of our Editorial Board Members towards open peer review on this biomedical journal.
authors.affiliation: BioMed Central Ltd, 236 Gray's Inn Road, London WC1X 8HL, UK. elizabeth.moylan@biomedcentral.com.
authors.forename: Elizabeth C
authors.initials: EC
authors.lastname: Moylan
authors.forename: Simon
authors.initials: S
authors.lastname: Harold
authors.forename: Ciaran
authors.initials: C
authors.lastname: O'Neill
authors.forename: Maria K
authors.initials: MK
authors.lastname: Kowalczuk
mesh_terms: D004311:Double-Blind Method; D017712:Peer Review, Research; D016037:Single-Blind Method